HCA Healthcare, Inc. (NYSE:HCA) Receives $473.53 Consensus Target Price from Brokerages

Shares of HCA Healthcare, Inc. (NYSE:HCA) have been assigned an average recommendation of “Moderate Buy” from the twenty-five research firms that are covering the stock, MarketBeat.com reports. Ten research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $473.5263.

A number of analysts have weighed in on the company. JPMorgan Chase & Co. increased their price target on HCA Healthcare from $360.00 to $370.00 and gave the stock a “neutral” rating in a report on Monday, August 4th. Truist Financial lifted their target price on HCA Healthcare from $460.00 to $495.00 and gave the stock a “buy” rating in a report on Monday, October 27th. Cowen reaffirmed a “buy” rating on shares of HCA Healthcare in a research report on Monday, October 27th. Bank of America increased their target price on shares of HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a research note on Monday, October 27th. Finally, Zacks Research raised shares of HCA Healthcare from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, October 29th.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares in the company, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.30% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On HCA Healthcare

A number of institutional investors have recently added to or reduced their stakes in HCA. Cheviot Value Management LLC purchased a new position in shares of HCA Healthcare in the 1st quarter worth approximately $26,000. Saudi Central Bank bought a new position in HCA Healthcare in the 1st quarter valued at $26,000. WPG Advisers LLC bought a new stake in shares of HCA Healthcare during the 1st quarter worth $27,000. Ameriflex Group Inc. bought a new position in HCA Healthcare during the second quarter valued at about $27,000. Finally, Chung Wu Investment Group LLC purchased a new position in HCA Healthcare in the second quarter valued at about $27,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $476.33 on Friday. The firm has a market cap of $108.70 billion, a P/E ratio of 18.41, a P/E/G ratio of 1.38 and a beta of 1.41. The stock’s 50 day moving average is $427.73 and its 200 day moving average is $391.34. HCA Healthcare has a one year low of $289.98 and a one year high of $478.88.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The firm had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. During the same quarter in the previous year, the company earned $4.90 EPS. The company’s revenue for the quarter was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities analysts anticipate that HCA Healthcare will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.13%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.